Fidelity's passive 8.5% stake is consistent with its role as a top institutional holder. No change in investment intent or activism signaled. Monitor future filings for any conversion to 13D, which would indicate a shift to active engagement.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 5 $392.48entry
- T+1 · 11d ago +1.87%α +1.56% · $399.81
- T+5 · 5d ago +4.80%α +1.50% · $411.30
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
FMR LLC (Fidelity) filed an amended Schedule 13G reporting beneficial ownership of 5,962,737.88 shares of West Pharmaceutical Services common stock as of September 30, 2026, representing 8.5% of shares outstanding. This is a routine passive stake update filed shortly after the company's strong Q3 2026 earnings report.
Key Financial Metrics
Key Facts
- FMR LLC reported beneficial ownership of 5,962,737.88 shares of West Pharmaceutical Services common stock as of September 30, 2026
- The stake represents 8.5% of shares outstanding
- Filing is an amendment to Schedule 13G, indicating passive investment intent
- Filed on November 5, 2026, with data as of September 30, 2026
- Fidelity Management & Research Company LLC is the entity within the FMR group that beneficially owns 5% or more
Financial Impact
FMR LLC holds 8.5% of WST common stock, valued at approximately $2.4B based on $28.4B market cap
Risk Factors
- No material risks identified from this routine passive stake update
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000315066-26-002889 |
| Document: 0000315066-26-002889-index-headers.html | 0000315066-26-002889 |
| Document: 0000315066-26-002889-index.html | 0000315066-26-002889 |
| Document: 0000315066-26-002889.txt | 0000315066-26-002889 |
Track record
17 reports on WST
2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +16.33% at T+60 after the Apr 23, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Viewing Entry $392.48 Now $417.80 +6.45% settles Feb 3
- Oct 29, 202618d ago 8-K Bullish 6/10 No price data
- Oct 29, 202618d ago Press Release Bullish 6/10 Entry $416.67 Now $417.80 +0.27% settles Jan 27
- Oct 26, 202621d ago 8-K Neutral 4/10 Entry $398.29 Now $417.80 +4.90% settles Jan 25
- Oct 26, 202621d ago Institutional Cluster Neutral 3/10 Entry $394.73 Now $417.80 +5.84% settles Jan 22
- Jul 23, 202616w ago 8-K Bullish 7/10 No price data
- Jul 23, 202616w ago Press Release Bullish 7/10 Entry $355.48 to $383.02 Now $417.80 +17.53% ▲ +7.75% +3.19% vs SPY
- Jul 7, 202618w ago Press Release Neutral 1/10 Entry $356.08 to $370.76 Now $417.80 +17.33% ▲ +4.12% +2.13% vs SPY
- May 11, 202627w ago 8-K Bearish 7/10 Entry $311.82 to $348.06 Now $417.80 −33.99% ▼ −11.62% −7.51% vs SPY
- Apr 27, 202629w ago Insider Cluster Neutral 2/10 Entry $300.93 to $358.41 Now $417.80 +38.83% ▲ +19.10% +14.59% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers